ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13317; 2) Community: the network communities that were significantly associated with the response to NSC 13317; 3) Molecule: the relationships between components within communities and NSC 13317; 4) MDR: the compounds that were significantly associated with the NSC 13317.

NSC Compound Enrichment Correlation
NSC 684459 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 4-(4-bromo- phenyl)-5,6-dihydro-2-phenyl- 0.00313644776247642 -0.22069231
NSC 696990 Null 0.00313644776247642 0.22420562
NSC 754328 Null 0.00313644776247642 0.61727557
NSC 677274 Uracil, 3-methyl-6-(phenylhydrazino)- 0.00356954838698631 0.373746
NSC 762542 Null 0.00356954838698631 0.43896114
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0035949310449002 0.33884028
NSC 746149 N,N'-bis(4-bromo-2-fluorobenzoyl)-L-selenocystine bis(4-methoxyphenacyl) ester hemihydrate 0.0035949310449002 -0.24591378
NSC 81052 Streptonigrin analog (MeO-N3) 0.0035949310449002 0.32476198
NSC 108165 CP 12252-1 0.00359493104490023 0.7525085
NSC 633963 N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride 0.00366577979610627 0.23343147
Total:70  Current:7    [First] [Prev] [Next] [Last]